Actively Recruiting
Real-world Patient Experiences With Inbrija4 Observational Study on Inhaled Levodopa for Managing OFF Episodes in Parkinsons Disease
Led by Merz Therapeutics GmbH · Updated on 2026-10-02
120
Participants Needed
2
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults with Parkinsons disease who experience OFF episodes, which are times when medication effects wear off and symptoms like movement difficulties return. The study explores the experiences of patients prescribed Inbrija4 as part of their regular care. It aims to understand how OFF episodes impact daily life, factors influencing the use of Inbrija4, and changes in patient-reported symptoms and quality of life over three months. Participants include adults with Parkinsons disease who either currently use Inbrija4 regularly or are starting it as part of routine care. The study uses a mixed-methods approach with two groups one group completes interviews about their experiences, while the other group completes questionnaires assessing symptoms and daily functioning during a three-month observation period. Treatment with Inbrija4 is prescribed by doctors independently of the study. During the study, participants engage in interviews or complete patient-reported outcome assessments at regular intervals over three months. Researchers measure changes in mobility using the PDQ-39 scale, as well as other aspects like daily activities, discomfort, and overall symptom severity. The study collects data to better understand patient experiences and outcomes with Inbrija4 in real-world clinical practice.
CONDITIONS
Brief Title
Real-world Patient Experiences With Inbrija®
Research Team
P
Public Disclosure Manager
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here